Explore

Re:Cognition Health Achieves Recertification for Clinical Site Assessment at U.S. Clinics

Re:Cognition Health Achieves Recertification for Clinical Site Assessment at U.S. Clinics

Re:Cognition Health, a leader in Alzheimer's Disease treatments, has successfully renewed its Global Clinical Site Assessment (GCSA) Site Certification at its four U.S. clinics located in Fairfax, Virginia; Chicago, Illinois; Houston, Texas; and Fort Worth, Texas. The certification, awarded by the International Accrediting Organization for Clinical Research (IAOCR), is a globally recognized standard for clinical research sites. Re:Cognition Health initially received this certification in 2024, becoming the first organization to achieve this in both the U.S. and Europe. The clinics are currently conducting 60 clinical trials related to Alzheimer's Disease, Mild Cognitive Impairment, Bipolar Disorder, Opioid Use Disorder, and more. The certification process involves a rigorous assessment across seven critical business operational areas to ensure high-quality clinical trials.

FDA Halts Newron's Schizophrenia Study After Patient Death, Safety Review Underway

FDA Halts Newron's Schizophrenia Study After Patient Death, Safety Review Underway

FDA Halts Newron's Schizophrenia Study After Patient Death, Safety Review Underway

FDA Launches Real-Time Clinical Trial Pilot with AstraZeneca and Amgen

FDA Launches Real-Time Clinical Trial Pilot with AstraZeneca and Amgen

FDA Launches Real-Time Clinical Trial Pilot with AstraZeneca and Amgen

Teva Pharmaceuticals Acquires Emalex Biosciences in $900 Million Deal to Expand Tourette Syndrome Treatment Options

Teva Pharmaceuticals Acquires Emalex Biosciences in $900 Million Deal to Expand Tourette Syndrome Treatment Options

Teva Pharmaceuticals Acquires Emalex Biosciences in $900 Million Deal to Expand Tourette Syndrome Treatment Options

Viz.ai and NRHA Partner to Implement AI in Rural Hospitals, Addressing Healthcare Disparities

Viz.ai and NRHA Partner to Implement AI in Rural Hospitals, Addressing Healthcare Disparities

Viz.ai has formed a strategic partnership with the National Rural Health Association (NRHA) to deploy AI-powered detection and coordination tools in rural hospitals across the United States. This collaboration aims to bridge the 'adoption gap' where rural hospitals are 25% less likely to adopt new technologies like AI compared to urban facilities, primarily due to funding and geographic barriers. The Viz platform is designed to analyze medical images and clinical data in real time, identifying life-threatening conditions such as stroke and pulmonary embolism. The initiative will provide rural hospital leaders with practical education through peer case studies, webinars, and strategic engagement at the NRHA national conference in May 2026. This effort is part of a broader strategy to enhance healthcare delivery in rural areas, which often face workforce shortages and limited access to specialists.

Bristol Myers Squibb Positions Cobenfy as a Safer Option for Alzheimer's Psychosis

Bristol Myers Squibb Positions Cobenfy as a Safer Option for Alzheimer's Psychosis

Bristol Myers Squibb Positions Cobenfy as a Safer Option for Alzheimer's Psychosis

NeuroPace's RNS System Shows Significant Seizure Reduction in Epilepsy Patients

NeuroPace's RNS System Shows Significant Seizure Reduction in Epilepsy Patients

NeuroPace's RNS System Shows Significant Seizure Reduction in Epilepsy Patients

St. Luke’s and Auxira Health Partner to Enhance Virtual Cardiology Services

St. Luke’s and Auxira Health Partner to Enhance Virtual Cardiology Services

St. Luke’s University Health Network has partnered with Auxira Health to expand its virtual cardiology support services. This collaboration introduces a physician-led, team-supported model that integrates virtual teams into St. Luke’s Heart & Vascular network. The initiative aims to improve patient access and reduce administrative burdens by providing cardiologists with virtual support teams composed of nurse practitioners, medical assistants, and registered nurses. The model is designed to streamline care coordination and follow-ups, allowing clinicians to focus on high-value patient interactions. The partnership is set to launch with 24 cardiologists and plans to expand across multiple locations in Pennsylvania and New Jersey.

Lasix ONYU Achieves CE Marking, Paving Way for European Market Entry

Lasix ONYU Achieves CE Marking, Paving Way for European Market Entry

Lasix ONYU Achieves CE Marking, Paving Way for European Market Entry

MRI Safe Neurostimulation Systems Market in the U.S. Analyzed for Future Growth

MRI Safe Neurostimulation Systems Market in the U.S. Analyzed for Future Growth

MRI Safe Neurostimulation Systems Market in the U.S. Analyzed for Future Growth

CenterWell's Fulfillment Index Highlights Emotional Well-Being as Key to Senior Health

CenterWell's Fulfillment Index Highlights Emotional Well-Being as Key to Senior Health

CenterWell's Fulfillment Index Highlights Emotional Well-Being as Key to Senior Health

Samuelis Donate $50 Million to Israeli Cancer Research at Beilinson Medical Center

Samuelis Donate $50 Million to Israeli Cancer Research at Beilinson Medical Center

Henry and Susan Samueli have made a significant philanthropic contribution by donating $50 million to Beilinson Medical Center in central Israel. This donation is aimed at advancing cancer treatment and research at the facility. The Samuelis' gift is part of a broader trend in philanthropy where donors are increasingly participating in collaborative efforts rather than establishing large, independent foundations. This approach allows for pooling resources and leveraging expertise to address global challenges more effectively. The donation is expected to enhance the medical center's capabilities in providing cutting-edge cancer care and conducting vital research.